Cucurbitacin I appears to be a potent inhibitor in meningioma cells and effective at concentrations similar to that effective on nasopharyngeal carcinoma cells [30] and lower than effective on ALK-positive anaplastic large cell lymphoma cells [32] and pancreatic carcinoma cells [29]. This evidence concerns the gene ALK and meningioma.